Cardiovascular Risk Management Redefined – What Else Should We Be Doing for Our Patients? was a GP education symposium held by The Harley Street Heart & Vascular Centre on 15 September 2018. The talks looked at how cardiovascular risk can be reduced further in patients who remain at high risk despite standard treatment. The full slide deck (120 slides) is available to download below.

15 September 2018

Topics covered

Risk reduction in ischaemic heart disease: lowering cholesterol to new depths

Presented by Dr Rohit Khurana. The talk reviewed the central role of LDL cholesterol in atherosclerosis, the dose-dependent effect of statins (the “rule of 6s”), residual risk after acute coronary syndrome, the outlook for statin-intolerant patients, and the evidence for adding ezetimibe or PCSK9 inhibitors to lower LDL cholesterol further. Related reading: high cholesterol, atherosclerosis, PCSK9 inhibitors and PCSK9 inhibitors vs statins.

Reducing risk in heart failure patients: new and traditional measures

Presented by Dr Peter Ting. The talk covered established and newer approaches to lowering risk in people living with heart failure. Related reading: heart failure.

Intervention and medical therapy in carotid and peripheral vascular disease

This session discussed how interventional procedures and medical therapy work together in managing carotid and peripheral arterial disease.

More resources for GPs